{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T02:30:45Z","timestamp":1772159445775,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T00:00:00Z","timestamp":1719964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014980","name":"Wannan Medical College","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014980","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["lipidjournal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jacl.2024.06.007","type":"journal-article","created":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T07:27:00Z","timestamp":1720164420000},"page":"e968-e976","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Association of lipids and lipid-lowering drugs with peripheral arterial disease: A Mendelian randomization study"],"prefix":"10.1016","volume":"18","author":[{"given":"Mengjun","family":"Tao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0317-9435","authenticated-orcid":false,"given":"Yuanxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuebing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Ping","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jacl.2024.06.007_bib0001","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1161\/CIR.0000000000001005","article-title":"Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: a scientific statement from the american heart association","volume":"144","author":"Criqui","year":"2021","journal-title":"Circulation"},{"issue":"360","key":"10.1016\/j.jacl.2024.06.007_bib0002","doi-asserted-by":"crossref","first-page":"5842","DOI":"10.1136\/bmj.j5842","article-title":"Peripheral artery disease","volume":"1","author":"Morley","year":"2018","journal-title":"BMJ"},{"issue":"9901","key":"10.1016\/j.jacl.2024.06.007_bib0003","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.jacl.2024.06.007_bib0004","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Working group. Inter-society consensus for the management of peripheral arterial disease (TASC II)","volume":"45","author":"Norgren","year":"2007","journal-title":"J Vasc Surg"},{"issue":"3","key":"10.1016\/j.jacl.2024.06.007_bib0005","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/HNP.0b013e3182157c4a","article-title":"The prevalence of asymptomatic and symptomatic peripheral arterial disease and peripheral arterial disease risk factors in the U.S. population","volume":"25","author":"Aponte","year":"2011","journal-title":"Holist Nurs Pract"},{"issue":"21","key":"10.1016\/j.jacl.2024.06.007_bib0006","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1161\/CIRCULATIONAHA.118.035432","article-title":"Lipoprotein particle profiles, standard lipids, and peripheral artery disease incidence","volume":"138","author":"Aday","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2024.06.007_bib0007","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1001\/jama.285.19.2481","article-title":"Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease","volume":"285","author":"Ridker","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2024.06.007_bib0008","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1067\/mhj.2002.122871","article-title":"Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study","volume":"143","author":"Murabito","year":"2002","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.jacl.2024.06.007_bib0009","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1024\/0301-1526\/a000689","article-title":"PCSK9 inhibition for LDL lowering and beyond - implications for patients with peripheral artery disease","volume":"47","author":"Gebauer","year":"2018","journal-title":"Vasa"},{"issue":"12","key":"10.1016\/j.jacl.2024.06.007_bib0010","article-title":"Safety of PCSK9 inhibitors","volume":"156","author":"Grze\u015bk","year":"2022","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"10.1016\/j.jacl.2024.06.007_bib0011","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.117.032235","article-title":"Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the fourier trial (further cardiovascular outcomes research with PCSK9 inhibition in subjects with elevated risk)","volume":"137","author":"Bonaca","year":"2018","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.jacl.2024.06.007_bib0012","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1161\/CIRCULATIONAHA.120.046524","volume":"141","author":"Schwartz","year":"2020","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jacl.2024.06.007_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ije\/dyg070","article-title":"Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?","volume":"32","author":"Smith","year":"2003","journal-title":"Int J Epidemiol"},{"issue":"8","key":"10.1016\/j.jacl.2024.06.007_bib0014","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/sim.3034","article-title":"Mendelian randomization: using genes as instruments for making causal inferences in epidemiology","volume":"27","author":"Lawlor","year":"2008","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.jacl.2024.06.007_bib0015","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13075-023-03122-7","article-title":"Causal relationship between PCSK9 inhibitor and autoimmune diseases: a drug target Mendelian randomization study","volume":"25","author":"Xie","year":"2023","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"10.1016\/j.jacl.2024.06.007_bib0016","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","article-title":"A cross-population atlas of genetic associations for 220 human phenotypes","volume":"53","author":"Sakaue","year":"2021","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacl.2024.06.007_bib0017","doi-asserted-by":"crossref","first-page":"16","DOI":"10.12688\/wellcomeopenres.16544.1","article-title":"Mendelian randomization for studying the effects of perturbing drug targets","volume":"6","author":"Gill","year":"2021","journal-title":"Wellcome Open Res"},{"issue":"9","key":"10.1016\/j.jacl.2024.06.007_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222362","article-title":"Robust methods in Mendelian randomization via penalization of heterogeneous causal estimates","volume":"14","author":"Rees","year":"2019","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.jacl.2024.06.007_bib0019","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.jacl.2024.06.007_bib0020","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"issue":"11","key":"10.1016\/j.jacl.2024.06.007_bib0021","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1038\/s41562-022-01412-9","article-title":"Bidirectional two-sample Mendelian randomization analysis identifies causal associations between relative carbohydrate intake and depression","volume":"6","author":"Yao","year":"2022","journal-title":"Nat Hum Behav"},{"issue":"5","key":"10.1016\/j.jacl.2024.06.007_bib0022","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from Mendelian randomization using the MR-Egger method","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur J Epidemiol"},{"issue":"S2","key":"10.1016\/j.jacl.2024.06.007_bib0023","article-title":"Impact of lifetime concentration of mannose on renal function: insights from Mendelian randomization","volume":"43","author":"Mazidi","year":"2022","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.jacl.2024.06.007_bib0024","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.kint.2021.06.041","article-title":"A Mendelian randomization study found causal linkage between telomere attrition and chronic kidney disease","volume":"100","author":"Park","year":"2021","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.jacl.2024.06.007_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004383","article-title":"Bayesian test for colocalisation between pairs of genetic association studies using summary statistics","volume":"10","author":"Giambartolomei","year":"2014","journal-title":"PLoS Genet"},{"issue":"159","key":"10.1016\/j.jacl.2024.06.007_bib0026","first-page":"49","article-title":"Role of dyslipidemia in accelerating inflammation, autoimmunity, and atherosclerosis in systemic lupus erythematosus and other autoimmune diseases","volume":"30","author":"Wang","year":"2020","journal-title":"Discov Med"},{"key":"10.1016\/j.jacl.2024.06.007_bib0027","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/hrt.72.2.128","article-title":"Peripheral vascular disease: consequence for survival and association with risk factors in the Speedwell prospective heart disease study","volume":"72","author":"Bainton","year":"1994","journal-title":"Br Heart J"},{"key":"10.1016\/j.jacl.2024.06.007_bib0028","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.118.035432","article-title":"Lipoprotein particle profiles, standard lipids, and peripheral artery disease incidence - prospective data from the women's health study","author":"Aday","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2024.06.007_bib0029","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1532-5415.2000.tb02652.x","article-title":"Risk factors for symptomatic peripheral arterial disease in older persons in an academic hospital-based geriatrics practice","volume":"48","author":"Ness","year":"2000","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"10.1016\/j.jacl.2024.06.007_bib0030","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2024.06.007_bib0031","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.atherosclerosis.2006.08.039","article-title":"The C679X mutation in PCSK9 is present and lowers blood cholesterol in a Southern African population","volume":"193","author":"Hooper","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2024.06.007_bib0032","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1042\/CS20070150","article-title":"The PCSK9 gene R46L variant is associated with lower plasma lipid levels and cardiovascular risk in UK healthy men","volume":"113","author":"Scartezini","year":"2007","journal-title":"Clin Sci"},{"key":"10.1016\/j.jacl.2024.06.007_bib0033","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.amjcard.2007.02.057","article-title":"Relation of PCSK9 mutations to serum low-density lipoprotein cholesterol in childhood and adulthood (from the Bogalusa Heart Study)","volume":"100","author":"Hallman","year":"2007","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.jacl.2024.06.007_bib0034","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2008.03.009","article-title":"Atherosclerosis risk in communities (ARIC) study investigators. Variation in PCSK9, low LDL cholesterol, and risk of peripheral arterial disease","volume":"202","author":"Folsom","year":"2009","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.jacl.2024.06.007_bib0035","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003497","article-title":"Plasma levels of proprotein convertase subtilisin\/kexin type 9 are elevated in patients with peripheral artery disease and associated with metabolic disorders and dysfunction in circulating progenitor cells","volume":"5","author":"Chao","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.jacl.2024.06.007_bib0036","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.coph.2008.12.017","article-title":"The monocyte\/macrophage as a therapeutic target in atherosclerosis","volume":"9","author":"Saha","year":"2009","journal-title":"Curr Opin Pharmacol"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193328742400206X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193328742400206X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T04:43:20Z","timestamp":1741149800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193328742400206X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S193328742400206X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2024.06.007","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of lipids and lipid-lowering drugs with peripheral arterial disease: A Mendelian randomization study","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2024.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 National Lipid Association. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}